U.S. Capital Markets Stock News

NasdaqGS:MNDY
NasdaqGS:MNDYSoftware

Is It Time To Rethink mondaycom MNDY After Its Sharp Multi Year Share Price Slide

Recent swings in monday.com’s share price may have you wondering whether the current level reflects a bargain, a fair deal, or something richer than the underlying business justifies. Over the short term, the stock has been mixed, with a 2.0% return over the last 7 days, a 4.7% decline over the last 30 days, and a year to date return of 54.1% decline that sits alongside a 76.2% decline over the past year and 40.2% decline over three years. Recent news flow has focused on how monday.com is...
NYSE:DAR
NYSE:DARFood

Darling Ingredients (DAR) Net Margin Squeeze Challenges Bullish Earnings Narratives

Darling Ingredients (DAR) opened Q1 2026 on the back of a steady run in 2025, with Q4 revenue of US$1.7b, basic EPS of US$0.36 and net income of US$56.9m setting the tone for how investors are reading the latest numbers against a market price of US$64.23. Over the last six reported quarters, the company has seen revenue move from US$1.4b in Q4 2024 to US$1.7b in Q4 2025. Quarterly basic EPS has ranged from a loss of US$0.16 in Q1 2025 to US$0.64 in Q4 2024, so the current release sits within...
NasdaqGM:ESCA
NasdaqGM:ESCALeisure

Escalade (ESCA) Margin Resilience Challenges Long Term Earnings Decline Narrative

Escalade (ESCA) has just put fresh numbers on the table, with recent quarters showing revenue between US$54.3 million and US$67.8 million and basic EPS ranging from roughly US$0.13 to US$0.41 per quarter. This sets the stage for a closer read on how the business is trending into Q1 2026. The company has seen revenue move from US$63.9 million in Q4 2024 to US$62.6 million in Q4 2025, while quarterly basic EPS over that stretch has shifted from US$0.20 to US$0.27 as part of a trailing twelve...
NYSE:GKOS
NYSE:GKOSMedical Equipment

Glaukos (GKOS) Q1 Loss Of US$0.34 EPS Reinforces Bearish Profitability Narrative

Glaukos (GKOS) has opened Q1 2026 with revenue of US$150.6 million and a basic EPS loss of US$0.34, while trailing twelve month revenue sits at US$551.3 million against a net loss of US$189.3 million. Over the past five reported quarters, revenue has moved from US$106.7 million in Q1 2025 to US$150.6 million in Q1 2026, as quarterly EPS losses ranged between US$0.28 and US$2.32. This keeps the spotlight firmly on how quickly the business can turn top line momentum into healthier margins. See...
NYSE:CSL
NYSE:CSLBuilding

Assessing Carlisle Companies (CSL) Valuation After Recent Share Price Rebound

What Carlisle Companies stock’s recent move tells you Carlisle Companies (CSL) shares recently closed at US$355.26, with the move coming after a mixed stretch that includes a 2.5% gain over the past day and a 2.3% decline over the past week. See our latest analysis for Carlisle Companies. That one day share price gain comes after a mixed few months, with a 30 day share price return of 6.5% and a 1 year total shareholder return of a 5.4% decline, while the 3 year total shareholder return of...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

Sprouts Farmers Market (SFM) Q1 EPS Strength Tests Bullish Earnings Growth Narrative

Sprouts Farmers Market (SFM) opened Q1 2026 with revenue of US$2.3b and basic EPS of US$1.73, giving investors a clear look at how the grocer is converting top line into per share profits. Over the last few quarters, revenue has moved from US$2.0b in Q4 2024 to US$2.2b in Q1 2025 and now US$2.3b in Q1 2026, while basic EPS has ranged from US$0.80 to US$1.83 across that stretch. With trailing 12 month EPS at US$5.24 and net income of US$507.4m, the latest print highlights how consistently the...
NYSE:EAT
NYSE:EATHospitality

Is Brinker International (EAT) Still Attractive After Strong Five-Year Share Price Performance?

If you are wondering whether Brinker International at around US$152 per share offers solid value or is pricing in too much optimism, you are not alone. The stock shows returns of 5.8% over 7 days, 6.6% over 30 days, 0.5% year to date and 17.1% over 1 year, with a very large 3 year gain and a 139.9% return over 5 years that many long term holders will be watching closely. Recent coverage has focused on how Brinker International is positioned within the Hospitality sector and what current...
NYSE:ED
NYSE:EDIntegrated Utilities

Assessing Consolidated Edison (ED) Valuation After Recent Share Price Stability And Mixed Cash Flow Signals

How Consolidated Edison Stock Has Been Performing Consolidated Edison (ED) has been relatively stable recently, with a 1 day return of 2.4% and a past week gain of 1.1%, while the month showed a 1.5% decline. Looking a bit longer, the stock shows a 4.6% return over the past 3 months and 11.5% year to date, with a 2.4% total return over the past year, 25.4% over 3 years, and 70.8% over 5 years. See our latest analysis for Consolidated Edison. At a share price of $111.49, Consolidated...
NYSE:BTU
NYSE:BTUOil and Gas

Do Rising BTU Earnings Estimates Amid Softer Outlook Reframe Peabody Energy’s Near‑Term Risk Profile?

In the lead-up to its March 2026 quarter results, Peabody Energy faced expectations of lower year-over-year earnings and revenue, even as analyst consensus earnings estimates were revised higher over the month. This combination of anticipated earnings pressure and improving estimates has drawn fresh attention to how closely analyst models align with Peabody’s near-term operating reality. We’ll now examine how the recent upward revisions to consensus earnings estimates could influence...
NYSE:TPL
NYSE:TPLOil and Gas

A Look At Texas Pacific Land (TPL) Valuation As Earnings Expectations Rise Ahead Of May 6 Report

Upcoming earnings put Texas Pacific Land (TPL) in focus Texas Pacific Land (TPL) is back on investors’ radar as the company approaches its May 6 earnings release, with expectations for higher year-over-year earnings and revenues for the March 2026 quarter. See our latest analysis for Texas Pacific Land. At a share price of $443.67, Texas Pacific Land has seen a 27.36% 90 day share price return and a 48.90% year to date share price return. The 3 year total shareholder return of 198.95% and 5...
NYSE:DLB
NYSE:DLBSoftware

A Look At Dolby Laboratories (DLB) Valuation After Earnings Growth And New BMW Atmos Partnership

Why Dolby’s latest earnings and BMW partnership matter for investors Dolby Laboratories (DLB) just released second quarter results with higher year over year revenue and net income, alongside a new BMW partnership that puts Dolby Atmos into the BMW 7 Series and additional models. This mix of earnings data and an automotive rollout of Dolby Atmos gives you fresh information on how the core licensing business and newer in car opportunities are developing at the same time. See our latest...
NYSE:MGY
NYSE:MGYOil and Gas

A Look At Magnolia Oil & Gas (MGY) Valuation After Recent Share Price Consolidation

Why Magnolia Oil & Gas is on investors’ radar today Magnolia Oil & Gas (MGY) continues to draw attention after recent share price moves, with the stock flat over the past day but showing mixed returns over the past week and month. For investors tracking energy producers, the company’s recent performance and current valuation metrics offer a fresh reference point when weighing Magnolia against other US exploration and production names. See our latest analysis for Magnolia Oil & Gas. That...
NYSE:HNGE
NYSE:HNGEHealthcare

Is It Time To Reconsider Hinge Health (HNGE) After Recent Digital Care Headlines?

If you are wondering whether Hinge Health at around US$44.60 is priced for opportunity or already reflects high expectations, the next sections will walk through what the current share price may be implying. The stock has recently shown mixed momentum, with a 3.1% move over the last 7 days, a 15.7% change over 30 days, and a year to date return of a 2.1% decline. Recent headlines have focused on Hinge Health's role in digital musculoskeletal care and its position within the broader...
NYSE:BLDR
NYSE:BLDRBuilding

Builders FirstSource Bets On Acquisitions To Support Growth And Margins

Builders FirstSource highlighted a renewed focus on acquisitions during its latest earnings call, pointing to M&A as a key growth lever. The company plans to use its free cash flow and integration track record to expand value added product offerings and extend its geographic footprint. This approach targets opportunities in a fragmented building products market, with implications for NYSE:BLDR and its competitive position. For investors watching NYSE:BLDR, the fresh emphasis on acquisitions...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

NovoCure (NVCR) Earnings Story Centers On 20.6% Revenue Growth Versus Ongoing Losses

NovoCure (NVCR) opened 2026 with Q1 results that follow a year where quarterly revenue ranged from about US$155 million to US$174 million and basic EPS stayed in loss-making territory between US$0.22 and US$0.36 per share. Over that stretch, revenue moved from US$161.3 million in Q4 2024 to US$174.4 million in Q4 2025, while quarterly net losses shifted between roughly US$24.5 million and US$65.9 million. This kept margins under pressure but gave investors a clear read on how top line growth...
NYSE:VMC
NYSE:VMCBasic Materials

Vulcan Materials (VMC) TTM Margin Expansion Tests Bullish Profitability Narratives

Vulcan Materials (VMC) opened 2026 with Q1 revenue of US$1.8b and basic EPS of US$1.27, supported by trailing twelve month revenue of US$8.1b and EPS of US$8.50 that frame the latest quarter in a broader earnings run rate. Over recent periods, the company has seen quarterly revenue move between US$1.6b and US$2.3b while EPS has ranged from US$0.98 to US$2.85, giving investors a clear view of how current figures sit within its recent history. With net income holding in the hundreds of millions...
NYSE:PSA
NYSE:PSASpecialized REITs

Is Public Storage (PSA) Offering Value After Recent Share Price Swings?

Wondering if Public Storage at around US$302 a share is offering fair value or a potential mispricing opportunity? This article walks through the key signals behind the stock. The share price has seen mixed short term moves, with a 2.7% decline over the last 7 days, an 11.7% gain over 30 days, and returns of 17.0% year to date and 5.1% over the last year. Evergreen interest in self storage REITs, ongoing coverage of real estate valuations, and regular attention on income focused stocks all...
NYSE:AWK
NYSE:AWKWater Utilities

American Water Works Company Q1 Margin Compression Challenges Bullish Profitability Narratives

American Water Works Company (AWK) opened 2026 with Q1 revenue of US$1.2 billion and basic EPS of US$1.01, setting the tone against a trailing twelve month EPS of US$5.65 on revenue of US$5.2 billion. Over the past year the company has seen quarterly revenue move from US$1.14 billion in Q1 2025 to US$1.21 billion in Q1 2026, while basic EPS shifted from US$1.05 to US$1.01, giving investors a clear view of steady top line performance alongside more contained earnings. With net income holding...
NYSE:TBBB
NYSE:TBBBConsumer Retailing

Is It Time To Reassess BBB Foods (TBBB) After Its 21% One Year Share Price Gain?

If you are wondering whether BBB Foods at around US$36.50 is a fair deal or starting to look expensive, this article breaks down what the current price could imply about the stock's value. The share price has seen a 2.1% decline over the last 7 days, a 3.2% gain over the past 30 days and a 6.2% return year to date, while the 1 year return sits at 21.1%. Recent coverage around BBB Foods has focused on its positioning within consumer retailing and how investors are weighing that against its...
NasdaqGS:ILPT
NasdaqGS:ILPTIndustrial REITs

Industrial Logistics Properties Trust (ILPT) Trailing FFO Of US$52.8 Million Tests Bearish Narratives

Industrial Logistics Properties Trust (ILPT) opened 2026 with Q1 reporting framed by recent figures that show total revenue at US$113.9 million in Q4 2025 and basic EPS at a loss of US$0.03 per share, while funds from operations reached US$17.9 million, or US$0.27 per share. Over the past few quarters, revenue has sat in a tight band between US$108.9 million and US$113.9 million, as EPS losses moved from US$0.38 in Q3 2024 to US$0.03 in Q4 2025 and trailing twelve month EPS registered at a...
NYSE:EFX
NYSE:EFXProfessional Services

Equifax Ataeva Credit Tools Launch Raises Questions On Undervalued Shares

Equifax (NYSE:EFX) and Ataeva have announced a new partnership to launch a diagnostic product suite for credit portfolio optimization. The new tools, Ataeva TAPS and Ataeva CYM, use Equifax credit data and proprietary attributes to help financial institutions identify high-value customers and assess portfolio profitability. The product suite is designed for banks and credit unions seeking more detailed insights into consumer credit behavior and market share opportunities. For readers...
NYSE:TT
NYSE:TTBuilding

Trane Technologies (TT) Margin Gain To 13.9% Tests Bearish Profitability Narratives

Trane Technologies (TT) opened Q1 2026 with Q4 2025 revenue of US$5.1b and basic EPS of US$2.74, setting the tone off the latest reported numbers as investors assess how the story is evolving. The company has seen quarterly revenue move from US$4.9b in Q4 2024 to US$5.1b in Q4 2025, while basic EPS shifted from US$2.67 to US$2.74 over the same period, with trailing twelve month EPS at US$13.25 on revenue of US$21.3b. With net profit margins higher over the last year, the setup for this...
NYSE:BDC
NYSE:BDCElectronic

Belden (BDC) Margin Expansion Strengthens Bullish Narratives Ahead Of Q1 2026 Earnings

Belden (BDC) has just put fresh numbers on the board for Q1 2026, coming off a Q4 2025 where revenue was US$720.1 million and basic EPS was US$1.73, supported by trailing twelve month EPS of US$6.00 on revenue of US$2.7 billion. Over the last few reported quarters, the company has seen revenue move from US$666.0 million in Q4 2024 to US$624.9 million in Q1 2025, then to US$671.9 million in Q2 2025 and US$698.2 million in Q3 2025, with EPS ranging between US$1.29 and US$1.73 over that stretch,...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

Alnylam Pharmaceuticals (ALNY) Earnings Turn To Profitability Challenges Premium P/E Narrative

Alnylam Pharmaceuticals (ALNY) opened 2026 on the back of a strong finish to last year, with Q4 2025 revenue of US$1.1b and basic EPS of US$1.41 supported by net income of US$186.4m as the company reported its latest numbers. Over the past few quarters, revenue has moved from US$593.2m in Q4 2024 to US$594.2m in Q1 2025, then to US$773.7m in Q2 2025 and US$1.25b in Q3 2025. Basic EPS shifted from a loss of US$0.65 in Q4 2024 to US$1.91 in Q3 2025 and US$1.41 in Q4 2025, reflecting a clear...